In a review article published Feb. 14 in The Lancet Oncology, Johns Hopkins experts identify three major sources of high cancer costs and argue that cancer doctors can likely reduce them without harm to patients.
Curie-Cancer, the body which leads the Institut Curie's industry partner research activity, and Servier, today announce that they have renewed their partnership with the aim of identifying therapeutic targets for treating ‘triple negative’ breast cancers. The partnership will continue for a further three years.
The Plaque-CharM project funded by the German Federal Ministry of Education and Research is to develop novel sensor technology that can characterise arterial tissue in the smallest space – the tip of a catheter.
The insight that psychological, social and environmental conditions affect a person’s health is insufficiently considered in medical training and in the every-day diagnosis and treatment of patients.
A Swiss and German researcher asked whether, where and how the Hospital Survey on Patient Safety Culture (HSOPS) is used in Europe and how relevant this survey – developed in the USA ten years ago and where it is widely accepted today – is in the European context.
Pain is the point of departure of any medical interaction. When a body sends out pain signals to say that something is wrong, the person in pain will react – either by selfmedication or by consulting a physician.
Johns Hopkins study finds robotic colon surgery just as effective as laparoscopy but more expensive
Prevention Suite’s four combined imaging technologies enables practical pre-clinical assessment of cardiovascular disease risk .
In May, 2013, the U.S. Food and Drug Administration (FDA) finally took the training wheels off tomosynthesis by approving the use of Hologic's new C-View 2D imaging in place of conventional 2D mammograms previously required as part of a breast tomosynthesis screening exam.
Healthcare is undergoing a major change set to offer a real prospect of far more genetically targeted treatments, according a leading human geneticist Sir John Burn, Professor of Clinical Genetics at Newcastle University, England.
Virtual observation of patients taking prescribed TB medication could prove an effective technique to ensure they effectively complete their treatment course, according to research presented at the European Respiratory Society (ERS) Annual Congress held in Barcelona.
Along with others, Germany has unanimously welcomed the revision of the EU directive on clinical trials. The change from mere guideline into a regulation valid in all member states, specifically aimed at making it easier to carry out multinational studies, is particularly welcomed, Bettina Döbereiner reports
Cancer diagnostics - Nanotechnology is currently being used in oncology to improve early tumour detection, imaging procedures and targeting of cancer therapies. Cancer biomarkers, indicators that are being produced by the body in spreading tumour cells, play an important role in cancer detection, Dr. Jörg Raach reports
Decontaminating every patient in an intensive care unit is a far more effective approach to controlling infections in hospitals, according to a new study, Mark Nicholls reports.
Despite one in five EU citizens suffering chronic pain, doctors across Europe are woefully under-educated about pain management, according to a major EU survey unveiled at The European Pain Federation (EFIC) Congress, held in Florence, Italy (October 10th).
Scientists at Imperial College in London, United Kingdom, have developed an ‘intelligent knife’ that instantly informs surgeons whether the tissue they are operating on is cancerous.
Through the miracle of modern-day ultrasound, we are able to see – in three dimensions and in real time – the functioning of arteries, veins and the many sophisticated structures of the heart. While most think of ultrasound technology as it relates to grinning parents getting a first glance of their baby in the womb, cardiovascular care is being revolutionised by advances in ultrasound…
The prototype of the open X-ray system ORBIT generates detailed 3-D images
Crowds of hospital delegates flocking in to Xiamen on the first day of CMEF had already suggested that the event will be welcoming more than the roughly 60,000 delegates expected to participate
At Bracco Suisse SA in Geneva all efforts are dedicated to contrast media for ultrasound scans. During their visit to the firm’s research centre and manufacturing site, Daniela Zimmermann and Ralf Mateblowski met with François Tranquart MD PhD, general manager of the Bracco Suisse research centre, to hear why SonoVue is now Europe’s most popular ultrasound contrast agent, with research…
Professor Axel Haverich and team at the Clinic for Cardiothoracic, Transplant and Vascular Surgery in Hanover Medical School (MHH) have been carrying out research into decellularised heart valves for over 15 years. They trialled a procedure – initially in the laboratory and in animal experiments – which does not cause tissue rejection, is hoped to last a lifetime and, in the case of children,…
Cooperation between the individual diagnostic fields of radiology, pathology and laboratory medicine has increased in daily clinical routine over the last few years. To a large extent, the three disciplines are faced with the same requirements and problems.
Nuclear medicine (NM) is the second largest source of medical radiation exposure after CT. However, patients who had a NM examination a decade ago most likely received a higher radiation dose than a patient in 2013.
Radiologists, EU policy makers and medical industry in drive to strengthen collaboration on personalised medicine
